Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -23.73% is 94% above its 5-year average of -396.12%, near the high end of its 5-year range (-1345.37%–-15.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 88.55% above its 12-month average of -207.15%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -23.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-23.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-207.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-503.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-396.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+88.55%
CURRENT VS 3Y AVG
+95.29%
CURRENT VS 5Y AVG
+94.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+33.46%
vs the sector median at left
TransCode Therapeutics, Inc.
Market Cap
$1.88M
Return on Invested Capital (ROIC)
-23.73%
TTM Avg
-207.15%
3Y Avg
-503.57%
5Y Avg
-396.12%
Market Cap
$1.88M
Return on Invested Capital (ROIC)
-518.15%
TTM Avg
-216.02%
3Y Avg
-220.11%
5Y Avg
-314.84%
Market Cap
$1.84M
Return on Invested Capital (ROIC)
-217.28%
TTM Avg
-171.07%
3Y Avg
-228.62%
5Y Avg
-200.11%
Market Cap
$1.84M
Return on Invested Capital (ROIC)
-106.06%
TTM Avg
-136.35%
3Y Avg
-128.44%
5Y Avg
-103.14%
Market Cap
$1.83M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-245.49%
3Y Avg
-245.49%
5Y Avg
-245.49%
Market Cap
$1.81M
Return on Invested Capital (ROIC)
-622.39%
TTM Avg
-214.75%
3Y Avg
-258.31%
5Y Avg
-197.46%
Market Cap
$2.13M
Return on Invested Capital (ROIC)
-985.20%
TTM Avg
-494.63%
3Y Avg
-376.51%
5Y Avg
-304.92%
Market Cap
$1.64M
Return on Invested Capital (ROIC)
-91.31%
TTM Avg
-71.66%
3Y Avg
-57.75%
5Y Avg
-71.28%
Market Cap
$2.14M
Return on Invested Capital (ROIC)
-182.30%
TTM Avg
-118.66%
3Y Avg
-275.59%
5Y Avg
-206.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransCode Therapeutics, Inc. (RNAZ) | $1.88M | -23.73% | -207.15% | -503.57% | -396.12% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | -518.15% | -216.02% | -220.11% | -314.84% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | -217.28% | -171.07% | -228.62% | -200.11% |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | -106.06% | -136.35% | -128.44% | -103.14% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | N/A | -245.49% | -245.49% | -245.49% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -622.39% | -214.75% | -258.31% | -197.46% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -985.20% | -494.63% | -376.51% | -304.92% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -91.31% | -71.66% | -57.75% | -71.28% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | -182.30% | -118.66% | -275.59% | -206.48% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | -163.98% | N/A | N/A | N/A |
ROIC
-23.7%
ROE
-30.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -23.73% |
| 2026-03-31 | -21.17% |
| 2025-12-31 | -17.61% |
| 2025-09-30 | -754.63% |
| 2025-06-30 | -218.61% |
| 2025-03-31 | -145.48% |
| 2024-12-31 | -343.36% |
| 2024-09-30 | -810.54% |
| 2024-06-30 | -1345.37% |
| 2024-03-31 | -388.42% |
| 2023-12-31 | -1156.48% |
| 2023-09-30 | -451.15% |
| 2023-06-30 | -869.89% |
| 2022-12-31 | -575.98% |
| 2022-09-30 | -195.59% |
| 2022-06-30 | -108.87% |
| 2022-03-31 | -53.99% |
| 2021-12-31 | -30.15% |
| 2021-09-30 | -15.31% |
| 2021-03-31 | -464.78% |
| 2020-12-31 | -111.70% |
| 2020-09-30 | -49.43% |
